Home » NCCN Backs Avastin for Breast Cancer
NCCN Backs Avastin for Breast Cancer
The future of Avastin (bevacizumab) as a breast cancer therapy took another turn when a major organization of cancer specialists voted to continue its support for the indication.
MedPage Today
MedPage Today
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May